Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
In addition, sustained intake of short-chain fatty acids (SCFAs) like propionic acid was reported to significantly increase the population of regulatory T (Treg) cells in MS patients
IM injection 1,000 mcg/month for severe cases
[DOI] [PubMed] [Google Scholar] 13.Kang E.A., Han Y.M., An J.M., Park Y.J., Sikiric P., Kim D.H., Kwon K.A., Kim Y.J., Yang D., Tchah H., et al
For short-term storage of a few weeks, a cool, dark, and dry place like a cupboard is sufficient